A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.
| Autor: | Torp-Pedersen C, Raev DH, Dickinson G, Butterfield NN, Mangal B, Beatch GN |
|---|---|
| Zdroj: | Circulation: Arrhythmia & Electrophysiology; Oct2011, Vol. 4 Issue 5, p637-643, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|